These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 27741342)

  • 1. Topical Minocycline Foam for the Treatment of Impetigo in Children: Results of a Randomized, Double-Blind, Phase 2 Study.
    Chamny S; Miron D; Lumelsky N; Shalev H; Gazal E; Keynan R; Shemer A; Tamarkin D
    J Drugs Dermatol; 2016 Oct; 15(10):1238-1243. PubMed ID: 27741342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, double-blind, comparative study to assess the safety and efficacy of topical retapamulin ointment 1% versus oral linezolid in the treatment of secondarily infected traumatic lesions and impetigo due to methicillin-resistant Staphylococcus aureus.
    Tanus T; Scangarella-Oman NE; Dalessandro M; Li G; Breton JJ; Tomayko JF
    Adv Skin Wound Care; 2014 Dec; 27(12):548-59. PubMed ID: 25396674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of retapamulin ointment as treatment of impetigo: randomized double-blind multicentre placebo-controlled trial.
    Koning S; van der Wouden JC; Chosidow O; Twynholm M; Singh KP; Scangarella N; Oranje AP
    Br J Dermatol; 2008 May; 158(5):1077-82. PubMed ID: 18341664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical retapamulin ointment, 1%, versus sodium fusidate ointment, 2%, for impetigo: a randomized, observer-blinded, noninferiority study.
    Oranje AP; Chosidow O; Sacchidanand S; Todd G; Singh K; Scangarella N; Shawar R; Twynholm M;
    Dermatology; 2007; 215(4):331-40. PubMed ID: 17911992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel topical minocycline foam for the treatment of moderate-to-severe acne vulgaris: Results of 2 randomized, double-blind, phase 3 studies.
    Gold LS; Dhawan S; Weiss J; Draelos ZD; Ellman H; Stuart IA
    J Am Acad Dermatol; 2019 Jan; 80(1):168-177. PubMed ID: 30165171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic Comparison of Once-Daily Topical Minocycline Foam 4% vs Oral Minocycline for Moderate-to-Severe Acne.
    Jones TM; Ellman H; deVries T
    J Drugs Dermatol; 2017 Oct; 16(10):1022-1028. PubMed ID: 29036256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical Antibacterial Agent for Treatment of Adult and Pediatric Patients With Impetigo: Pooled Analysis of Phase 3 Clinical Trials.
    Hebert AA; Albareda N; Rosen T; Torrelo A; Grimalt R; Rosenberg N; Zsolt I; Masramon X
    J Drugs Dermatol; 2018 Oct; 17(10):1051-1057. PubMed ID: 30365584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating FMX-101 as a promising therapeutic for the treatment of acne.
    Valente Duarte de Sousa IC
    Expert Opin Pharmacother; 2020 May; 21(7):741-746. PubMed ID: 32037906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The safety and efficacy of topical retapamulin ointment versus placebo ointment in the treatment of secondarily infected traumatic lesions: a randomized, double-blind superiority study.
    Tomayko JF; Li G; Breton JJ; Scangarella-Oman N; Dalessandro M; Martin M
    Adv Skin Wound Care; 2013 Mar; 26(3):113-21. PubMed ID: 23426412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of calcipotriene 0.005% foam for the treatment of plaque-type psoriasis: results of two multicenter, randomized, double-blind, vehicle-controlled, phase III clinical trials.
    Feldman SR; Matheson R; Bruce S; Grande K; Markowitz O; Kempers S; Brundage T; Wyres M;
    Am J Clin Dermatol; 2012 Aug; 13(4):261-71. PubMed ID: 22587791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ozenoxacin 1% cream in the treatment of impetigo: a multicenter, randomized, placebo- and retapamulin-controlled clinical trial.
    Gropper S; Albareda N; Chelius K; Kruger D; Mitha I; Vahed Y; Gani M; García-Alonso F;
    Future Microbiol; 2014; 9(9):1013-23. PubMed ID: 25340832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impetigo contagiosa III. Comparative efficacy of oral erythromycin and topical mupirocin.
    Barton LL; Friedman AD; Sharkey AM; Schneller DJ; Swierkosz EM
    Pediatr Dermatol; 1989 Jun; 6(2):134-8. PubMed ID: 2501775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Safety of Ozenoxacin Cream for Treatment of Adult and Pediatric Patients With Impetigo: A Randomized Clinical Trial.
    Rosen T; Albareda N; Rosenberg N; Alonso FG; Roth S; Zsolt I; Hebert AA
    JAMA Dermatol; 2018 Jul; 154(7):806-813. PubMed ID: 29898217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of besifloxacin ophthalmic suspension 0.6% administered twice daily for 3 days in the treatment of bacterial conjunctivitis: a multicenter, randomized, double-masked, vehicle-controlled, parallel-group study in adults and children.
    Silverstein BE; Allaire C; Bateman KM; Gearinger LS; Morris TW; Comstock TL
    Clin Ther; 2011 Jan; 33(1):13-26. PubMed ID: 21397770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ozenoxacin, a New Effective and Safe Topical Treatment for Impetigo in Children and Adolescents.
    Torrelo A; Grimalt R; Masramon X; Albareda López N; Zsolt I
    Dermatology; 2020; 236(3):199-207. PubMed ID: 31958794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized clinical trial of topical mupirocin versus oral erythromycin for impetigo.
    Goldfarb J; Crenshaw D; O'Horo J; Lemon E; Blumer JL
    Antimicrob Agents Chemother; 1988 Dec; 32(12):1780-3. PubMed ID: 3149884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and treatment of impetigo.
    Cole C; Gazewood J
    Am Fam Physician; 2007 Mar; 75(6):859-64. PubMed ID: 17390597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical retapamulin ointment (1%, wt/wt) twice daily for 5 days versus oral cephalexin twice daily for 10 days in the treatment of secondarily infected dermatitis: results of a randomized controlled trial.
    Parish LC; Jorizzo JL; Breton JJ; Hirman JW; Scangarella NE; Shawar RM; White SM;
    J Am Acad Dermatol; 2006 Dec; 55(6):1003-13. PubMed ID: 17097398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impetigo: diagnosis and treatment.
    Hartman-Adams H; Banvard C; Juckett G
    Am Fam Physician; 2014 Aug; 90(4):229-35. PubMed ID: 25250996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical mupirocin treatment of impetigo is equal to oral erythromycin therapy.
    Mertz PM; Marshall DA; Eaglstein WH; Piovanetti Y; Montalvo J
    Arch Dermatol; 1989 Aug; 125(8):1069-73. PubMed ID: 2502950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.